Stocks · Health care · Pharmaceutical Preparations

Vyome Holdings, Inc

HIND Clue Score22
United States Fiscal year ends December CIK 0001427570
$2.09 +2.96% Close, 9 Oct 2026
Price $2.09 −24.28% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue3.4Operating income−19.5Net income−20.5Fiscal year 2017Revenue9.9 +192.2%Operating income−34.4Net income−34.8Fiscal year 2018Revenue9.1 −8.2%Operating income−37.0Net income−37.4Fiscal year 2019Revenue3.3 −63.9%Operating income−23.2Net income−23.7Fiscal year 2020Revenue11.3 +244.4%Operating income−12.5Net income−21.6EPS, diluted−5.54Fiscal year 2021Revenue13.6 +20.4%Operating income−57.9Net income−63.1EPS, diluted−288.97Fiscal year 2022Revenue11.2 −17.4%Operating income−46.4Net income−46.2EPS, diluted−108.90Fiscal year 2023Revenue8.7 −22.8%Operating income−15.4Net income−11.4EPS, diluted−110.87Fiscal year 2024Revenue8.0 −7.7%Operating income−1.0Net income−1.4EPS, diluted−6,001.39Fiscal year 2025Revenue0.3 −96.0%Operating income−10.5Net income−10.3EPS, diluted−4.86
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 3.4 9.9 9.1 3.3 11.3 13.6 11.2 8.7 8.0 0.3
Growth +192.2% −8.2% −63.9% +244.4% +20.4% −17.4% −22.8% −7.7% −96.0%
Operating income −19.5 −34.4 −37.0 −23.2 −12.5 −57.9 −46.4 −15.4 −1.0 −10.5
Net income −20.5 −34.8 −37.4 −23.7 −21.6 −63.1 −46.2 −11.4 −1.4 −10.3
Growth
EPS, diluted n/a n/a n/a n/a −5.54 −288.97 −108.90 −110.87 −6,001.39 −4.86

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin17.2%Operating margin−574.9%Net margin−603.2%Free cash flow margin−581.2%Fiscal year 2017Gross margin51.3%Operating margin−346.9%Net margin−350.7%Free cash flow margin−319.4%Fiscal year 2018Gross margin40.4%Operating margin−406.2%Net margin−410.7%Free cash flow margin−337.5%Fiscal year 2019Gross margin10.1%Operating margin−708.0%Net margin−721.6%Free cash flow margin−702.8%Fiscal year 2020Gross margin55.4%Operating margin−110.2%Net margin−191.4%Free cash flow margin−77.2%Fiscal year 2021Gross margin61.4%Operating margin−425.6%Net margin−464.3%Free cash flow margin−115.6%Fiscal year 2022Gross margin60.5%Operating margin−412.4%Net margin−411.2%Free cash flow margin−196.0%Fiscal year 2023Gross margin63.9%Operating margin−177.3%Net margin−131.2%Free cash flow margin−195.9%Fiscal year 2024Gross margin2.4%Operating margin−12.6%Net margin−18.1%Fiscal year 2025Gross margin68.4%Operating margin−3,269.4%Net margin−3,209.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 17.2% 51.3% 40.4% 10.1% 55.4% 61.4% 60.5% 63.9% 2.4% 68.4%
Operating margin −574.9% −346.9% −406.2% −708.0% −110.2% −425.6% −412.4% −177.3% −12.6% −3,269.4%
Net margin −603.2% −350.7% −410.7% −721.6% −191.4% −464.3% −411.2% −131.2% −18.1% −3,209.7%
Free cash flow margin −581.2% −319.4% −337.5% −702.8% −77.2% −115.6% −196.0% −195.9% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−19.4Capital expenditure−0.4Free cash flow−19.7Fiscal year 2017Operating cash flow−30.6Capital expenditure−1.0Free cash flow−31.7Fiscal year 2018Operating cash flow−29.4Capital expenditure−1.3Free cash flow−30.7Fiscal year 2019Operating cash flow−22.9Capital expenditure−0.2Free cash flow−23.1Fiscal year 2020Operating cash flow−8.6Capital expenditure−0.2Free cash flow−8.7Fiscal year 2021Operating cash flow−15.4Capital expenditure−0.4Free cash flow−15.7Fiscal year 2022Operating cash flow−21.9Capital expenditure−0.1Free cash flow−22.0Fiscal year 2023Operating cash flow−17.0Capital expenditure−0.0Free cash flow−17.0Fiscal year 2024Operating cash flow−0.6Fiscal year 2025Operating cash flow−3.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −19.4 −30.6 −29.4 −22.9 −8.6 −15.4 −21.9 −17.0 −0.6 −3.7
Capital expenditure −0.4 −1.0 −1.3 −0.2 −0.2 −0.4 −0.1 −0.0 n/a n/a
Free cash flow −19.7 −31.7 −30.7 −23.1 −8.7 −15.7 −22.0 −17.0 n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash73.0Total debt9.9Net cash (debt)63.1Shareholders’ equity64.3Debt to equity0.15Fiscal year 2017Cash21.1Total debt9.9Net cash (debt)11.2Shareholders’ equity35.1Debt to equity0.28Fiscal year 2018Cash21.2Total debt9.9Net cash (debt)11.3Shareholders’ equity13.1Debt to equity0.76Fiscal year 2019Cash14.1Total debt0.0Net cash (debt)14.1Shareholders’ equity24.1Debt to equity0.00Fiscal year 2020Cash3.0Total debt12.8Net cash (debt)−9.8Shareholders’ equity14.5Debt to equity0.88Fiscal year 2021Cash22.8Shareholders’ equity44.3Fiscal year 2022Cash3.9Shareholders’ equity3.7Fiscal year 2023Cash4.5Shareholders’ equity6.7Fiscal year 2024Cash0.1Shareholders’ equity−0.3Fiscal year 2025Cash5.0Shareholders’ equity3.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 73.0 21.1 21.2 14.1 3.0 22.8 3.9 4.5 0.1 5.0
Total debt 9.9 9.9 9.9 0.0 12.8 n/a n/a n/a n/a n/a
Net cash (debt) 63.1 11.2 11.3 14.1 −9.8 n/a n/a n/a n/a n/a
Shareholders’ equity 64.3 35.1 13.1 24.1 14.5 44.3 3.7 6.7 −0.3 3.8
Debt to equity 0.15 0.28 0.76 0.00 0.88 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Operations
−19.4 −30.6 −29.4 −22.9 −8.6 −15.4 −21.9 −17.0 −0.6 −3.7
Growth
Investment
−0.4 −1.0 −1.3 −0.2 −0.2 −0.4 −0.1 −0.0 n/a n/a
calc −19.7 −31.7 −30.7 −23.1 −8.7 −15.7 −22.0 −17.0 n/a n/a
Growth
calc n/a n/a n/a n/a −2.23 −71.97 −51.92 −165.55 n/a n/a
6.2 −21.9 19.5 2.4 −2.4 1.9 −0.1 −0.0 0.0 n/a
Financing
82.8 0.6 10.0 13.4 11.1 33.3 3.1 17.6 0.7 8.7

† The diluted share count jumps at 2021 and 2022 and 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.